morning and you good and continued Diana, China for of Pharma. today like support you, for to Thank each I your everyone. joining of thank us would
revenue of in to XXXX basic receive period increased industry sales in impact through gross reform major of Management increasing market and patterns. drug future generic the openings tender sales drug was will policies ongoing top drug may development year generating of business slightly to in the consistency the on The recent control. priority. vigorously medical and to third provincial similar and and evaluations market. new will production a performance last research further and its have the better Nevertheless, participation the quarter through margin same due our to offers China's remains Our continue cost review we change registration active promote our of
read English. to continue order existing development now the the further Ms. will remarks policy rest actively conditions pipeline adapt in products, guidance to We products, competition market to strategy." I our prepared current evaluate and in our Li's and for optimize of market in will state
$X.X profit months I our million review XXXX ended three million our and XX, months ended $X.X were Gross and million September financial for Now would $X.X the sheet information. and was balance million and like third XX, for XXXX quarter the respectively. to XXXX respectively. XXXX Revenues XXXX, results $X.X three September and
the XXXX. compared profit margin of same Our XX.X% was XXXX in quarter to gross third period the in XX.X%
processes in sales selling and $X our quarter collection support in of in sales, for the adjustments which despite revenue the XXXX,compared accounted many proportionally our ended to to of the expenses maintain the we of Our selling continue XXXX, expenses three XX.X% for to to reform under personnel third million activities of XX, the decrease to were policies, revenue the of quarter for $X.X sales. XXXX and our September million, accounted same our still XX.X% sales months total healthcare for which third not decrease period Due total in accounts need the XXXX. therefore did selling receivable, the
and and three and revenues XX% September general accounted were expenses our months total X.X% of $X.X Our administrative XX, and million. for in XXXX, third for both quarters September and XXXX, the XXXX ended respectively. of XX, XXXX expenses General the administrative
in September for of $X.X change compared ended due aged months three ended expense bad receivables. The XXXX of was XX, to the million, to the million September debt bad accounts XX, was months XXXX. Our three increase benefit $X.X a debt the
made third were impaired. independent the advances quarter the contracts advances independent to and with made intangible the of two two for Company relating reviewed assets of for formulas During laboratories XXXX laboratories by determined purchases to Company that the
of was the the same profit XX, compared the the for million. $X.X net ended profit an were as Net $X.X to increase compared result, three $X.X in the to was $XX.X asset term impairments XX, of formula net the million, for Nine XXXX, the of advances The mainly laboratory months corresponding million nine same $X.X in decrease million represented same ended third recognized September in the $X.X million and XXXX, the months in XXXX. loss months million, the nine a of $X.X XX%, and loss one for a margin the or September result respectively. ended XX, in for our period Gross compared recognized one XXXX to $X.X evaluation. September million XXXX. of to XXXX laboratories of of Company the months these $X.X to for advances company the Gross the As In sales impairment impairment for nine million, September from revenue long million, the made loss was due XX, months September XX, per in the XXXX. ended was also made XXXX. period period months XXXX ended change amount three loss period of XX% the XXXX X.X%, quarter to XXXX for the which results; for in
Our selling XX, to decrease the of accounted compared September expenses million, XXXX of expenses XX.X% nine and million were XX.X% XX%, same of first XXXX the XXXX. $X.X nine Selling a and for $X.X total period months in for months $X.X million, the XXXX respectively. ended of or revenue the for
million. nine Our September expenses general XXXX the XXXX XX, ended and for $X.X both were administrative and months
Our bad $X million. debt months XXXX XX, September and nine both ended the XXXX for expenses were
to the independent purchases for by During the the laboratories nine independent determined months the relating ended advances contracts of advances and two made were Company for XXXX, formulas the to that Company assets reviewed with three the made September laboratories XX, of impaired. intangible
made recognized the impairment for of for As Company recognized the a company $X.X the three the $X.X result, loss one advances the formula same In the laboratories amount to impairment in laboratories an made for million XXXX, those to the also period million. loss evaluation. advances in per
diluted the million, share $X.XX nine the XXXX and for million, the loss for $X per million September to XXXX, same nine ended $X.X approximately or compared million, for was XXXX. period September $X.X operating diluted XX, was basic XX, year and months for share, ended same $X.X the or to months per a Net ago. of basic Our $X.XX compared loss period
of $X.X XX, cash XXXX. as Turning XX, equivalents the Company as had of Working compared March cash of XXXX, million March from and to the of XX, $X.X XXXX $X.X to balance decreased sheet, XXXX. million December $X.X million million to of as as XX, capital December
XXXX March to receivable XXXX. million balance decreased XX, of Our $X.X from as of XX, December accounts million as $X
of cash equivalents XXXX. of XX, As as from of September and $X.X as XX, XXXX. December December of decreased million cash $X.X had XXXX million to to of $X.X XXXX, $X.X Working million compared million the Company capital XX, XX, September as
promote our Overall, As open of our beliefs we XXXX, shareholders we questions. of to our now in September to December future. sales With the evaluation up this million to that receivable that, our will on million, call Operator? the the will focusing XX, net increase of fair business support accounts and will developments the was continue $X as XX, and $X.X compared XXXX.
